130 related articles for article (PubMed ID: 24623229)
1. Mutagen sensitivity as measured by induced chromatid breakage as a marker of cancer risk.
Wu X; Zheng YL; Hsu TC
Methods Mol Biol; 2014; 1105():183-92. PubMed ID: 24623229
[TBL] [Abstract][Full Text] [Related]
2. Mutagen-induced chromatid breakage as a marker of cancer risk.
Wu X; Zheng YL; Hsu TC
Methods Mol Biol; 2005; 291():59-67. PubMed ID: 15502212
[TBL] [Abstract][Full Text] [Related]
3. Mutagen sensitivity as a marker of cancer risk.
Spitz MR; Hsu TC
Cancer Detect Prev; 1994; 18(4):299-303. PubMed ID: 7526974
[TBL] [Abstract][Full Text] [Related]
4. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions.
Wu X; Lippman SM; Lee JJ; Zhu Y; Wei QV; Thomas M; Hong WK; Spitz MR
Cancer Res; 2002 May; 62(10):2813-8. PubMed ID: 12019158
[TBL] [Abstract][Full Text] [Related]
5. DNA repair capacity correlates with mutagen sensitivity in lymphoblastoid cell lines.
Wei Q; Spitz MR; Gu J; Cheng L; Xu X; Strom SS; Kripke ML; Hsu TC
Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):199-204. PubMed ID: 8833620
[TBL] [Abstract][Full Text] [Related]
6. Three measures of mutagen sensitivity in a cancer-free population.
Gu J; Bondy ML; Sigurdson A; Spitz MR; Hsu TC; Wu X
Cancer Genet Cytogenet; 1999 Apr; 110(1):65-9. PubMed ID: 10198626
[TBL] [Abstract][Full Text] [Related]
7. Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma.
Wu X; Gu J; Patt Y; Hassan M; Spitz MR; Beasley RP; Hwang LY
Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):567-70. PubMed ID: 9681523
[TBL] [Abstract][Full Text] [Related]
8. A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung carcinoma cases and controls.
Wu X; Gu J; Amos CI; Jiang H; Hong WK; Spitz MR
Cancer; 1998 Sep; 83(6):1118-27. PubMed ID: 9740076
[TBL] [Abstract][Full Text] [Related]
9. Mutagen sensitivity has high heritability: evidence from a twin study.
Wu X; Spitz MR; Amos CI; Lin J; Shao L; Gu J; de Andrade M; Benowitz NL; Shields PG; Swan GE
Cancer Res; 2006 Jun; 66(12):5993-6. PubMed ID: 16778168
[TBL] [Abstract][Full Text] [Related]
10. Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract.
Wu X; Gu J; Hong WK; Lee JJ; Amos CI; Jiang H; Winn RJ; Fu KK; Cooper J; Spitz MR
J Natl Cancer Inst; 1998 Sep; 90(18):1393-9. PubMed ID: 9747870
[TBL] [Abstract][Full Text] [Related]
11. Mutagen sensitivity exhibits a dose-response relationship in case-control studies.
Wu X; Hsu TC; Spitz MR
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):577-8. PubMed ID: 8827363
[TBL] [Abstract][Full Text] [Related]
12. Mutagen sensitivity: a genetic predisposition factor for cancer.
Wu X; Gu J; Spitz MR
Cancer Res; 2007 Apr; 67(8):3493-5. PubMed ID: 17440053
[TBL] [Abstract][Full Text] [Related]
13. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer.
Wei Q; Gu J; Cheng L; Bondy ML; Jiang H; Hong WK; Spitz MR
Cancer Res; 1996 Sep; 56(17):3975-9. PubMed ID: 8752166
[TBL] [Abstract][Full Text] [Related]
14. DNA repair and mutagen sensitivity in patients with triple primary cancers.
Miller DG; Tiwari R; Pathak S; Hopwood VL; Gilbert F; Hsu TC
Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):321-7. PubMed ID: 9568788
[TBL] [Abstract][Full Text] [Related]
15. Involvement of cell cycle control in bleomycin-induced mutagen sensitivity.
Cloos J; Temmink O; Ceelen M; Snel MH; Leemans CR; Braakhuis BJ
Environ Mol Mutagen; 2002; 40(2):79-84. PubMed ID: 12203399
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal alterations and mutagen sensitivity in human mucosal cells of the oropharynx and lymphocytes caused by BPDE.
Reiter M; Baumeister P; Zieger S; Harréus U
Cancer Genomics Proteomics; 2009; 6(5):247-54. PubMed ID: 19996129
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study.
Xiong P; Bondy ML; Li D; Shen H; Wang LE; Singletary SE; Spitz MR; Wei Q
Cancer Res; 2001 Dec; 61(23):8465-9. PubMed ID: 11731429
[TBL] [Abstract][Full Text] [Related]
18. Removal of benzo(a)pyrene diol epoxide (BPDE)-DNA adducts as a measure of DNA repair capacity in lymphoblastoid cell lines from sisters discordant for breast cancer.
Motykiewicz G; Faraglia B; Wang LW; Terry MB; Senie RT; Santella RM
Environ Mol Mutagen; 2002; 40(2):93-100. PubMed ID: 12203401
[TBL] [Abstract][Full Text] [Related]
19. DNA repair phenotype and cancer susceptibility--a mini review.
Li C; Wang LE; Wei Q
Int J Cancer; 2009 Mar; 124(5):999-1007. PubMed ID: 19065660
[TBL] [Abstract][Full Text] [Related]
20. Microarray analysis of bleomycin-exposed lymphoblastoid cells for identifying cancer susceptibility genes.
Cloos J; de Boer WP; Snel MH; van den Ijssel P; Ylstra B; Leemans CR; Brakenhoff RH; Braakhuis BJ
Mol Cancer Res; 2006 Feb; 4(2):71-7. PubMed ID: 16513838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
